Njinkeng J Nkemngu Etienne D N Asonganyi Anna L Njunda
10.1186/1471-2334-5-49
BMC Infect Dis
2005 Jun 21;5:49.
CC BY
https://pubmed.ncbi.nlm.nih.gov/15969764/
Ciprofloxacin / pharmacology Ciprofloxacin / therapeutic use Drug Resistance, Multiple, Bacterial Nalidixic Acid / pharmacology Salmonella typhi / drug effects Typhoid Fever / drug therapy Typhoid Fever / microbiology
Ciprofloxacin / pharmacology Ciprofloxacin / therapeutic use Drug Resistance, Multiple, Bacterial Nalidixic Acid / pharmacology Salmonella typhi / drug effects Typhoid Fever / drug therapy Typhoid Fever / microbiology Case Reports Adult Anti-Bacterial Agents / therapeutic use Cameroon Ceftriaxone / therapeutic use Female Humans Microbial Sensitivity Tests Treatment Failure Anti-Bacterial Agents Nalidixic Acid Ciprofloxacin Ceftriaxone
PMC1184073
15969764
Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon
2005